XML 281 R77.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Earnings (loss) per Share - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  | 0 |
Percentage of Shares Issued under award | 9.30% |  | 12.00%
Public Warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options | 8,625,000 |  |
Class of warrant or right exercise price of warrants or rights | $ 11.50 |  | $ 11.50
Private Placement Warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options | 506,250 |  |
Conversion price of promissory notes | $ 11.50 |  |
Class of warrant or right exercise price of warrants or rights |  |  | 11.50
Financing warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options | 340,250 |  |
Conversion price of promissory notes | $ 11.50 |  |
Class of warrant or right exercise price of warrants or rights |  |  | $ 11.50
Financing Note |  |  |
Earnings (loss) per Share |  |  |
Total face value of the convertible notes |  |  | $ 6,805
Conversion price of promissory notes |  |  | $ 10.00
Financing Note |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 680,500
Interest payments on financing notes |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 2,245,650
Public Warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 8,625,000
Earnout shares |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 2,400,000
Private Placement Warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 506,250
Financing warrants |  |  |
Earnings (loss) per Share |  |  |
Shares excluded as antidilutive relating to stock options |  |  | 340,250

X
- Definition The percentage of shares issued in Business combination as of fully diluted shares. + References No definition available. + Details
Name: | msai_PercentageOfSharesIssuedUnderAwardOfFullyDilutedSharesAsOfBusinessCombination
Namespace Prefix: | msai_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_DebtConversionOriginalDebtAmount1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The price per share of the conversion feature embedded in the debt instrument. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5 + Details
Name: | us-gaap_DebtInstrumentConvertibleConversionPrice1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=msai_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=msai_PrivatePlacementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=msai_FinancingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=msai_FinancingNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_FinancingNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_InterestPaymentsOnFinancingNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_EarnoutSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_PrivatePlacementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=msai_FinancingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |